Skip to content

Sinovac Biotech Ltd

SVA· NasdaqCore metricsCIK 1084201

Pharmaceutical preparations552 peers

Close
Jun 30, 2026
Market cap
$464.93M
71.86M shares
Filings
578
$386.01M
FY 2025+6.8% FY25 yoy
-$198.84M
FY 2025N/M FY25 yoy
-$490.13M
FY 2025N/M FY25 yoy
-$561.10M
FY 2025derivedN/M FY25 yoy
-$0.83
FY 2025N/M FY25 yoy
$488.25M
FY 2025+45.6% FY25 yoy
$464.93M
—
1.2×
0.1×
-120.68%
760.19%

FY2025 figures · derived

Price

$6.470.00%$0.00past year
Jun 30, 2026 · 13F quarter end
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$386.01MFY 2025
$19.37B0FY 2015FY 2020FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$386,013,000reported
FY 20242024-12-31$361,374,000reported
FY 20232023-12-31$470,170,000 revisedreported
FY 20222022-12-31$1,473,427,000 revisedreported
FY 20212021-12-31$19,365,354,000 revisedreported
FY 20202020-12-31$510,624,000reported
FY 20192019-12-31$246,053,000reported
FY 20182018-12-31$229,650,000reported
FY 20172018-01-01$3,888,000reported
FY 20162016-12-31$72,431,000reported
FY 20152015-12-31$67,414,000reported

Capital returns

Dividends and buybacks · FY2010 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$3.53B—$3.53B$55.0071.86M sh±0.0%—
FY2024$947.00M—$947.00M—71.86M sh−27.9%—
FY2023$328.08M—$328.08M—99.64M sh+0.1%—
FY2022$247.40M—$247.40M—99.50M sh±0.0%—
FY2021$1.88B—$1.88B—99.50M sh+0.2%12.7%

Segments

Geography
Revenue by Geography, FY2018 to FY2025FY2018PRC · FY2018 · $215.12MOutside Mainland China · FY2018 · $14.53MFY2019PRC · FY2019 · $227.11MOutside Mainland China · FY2019 · $18.94MFY2020PRC · FY2020 · $365.62MOutside Mainland China · FY2020 · $145.00MFY2021PRC · FY2021 · $10.90BOutside Mainland China · FY2021 · $8.47BFY2022PRC · FY2022 · $1.07BOutside Mainland China · FY2022 · $398.74MFY2023PRC · FY2023 · $402.96MOutside Chinese Mainland · FY2023 · $67.21MOutside Mainland China · FY2023 · $67.21MFY2024PRC · FY2024 · $297.00MOutside Chinese Mainland · FY2024 · $64.37MOutside Mainland China · FY2024 · $64.37MFY2025PRC · FY2025 · $261.18MOutside Chinese Mainland · FY2025 · $124.83M
LineFY2025ShareChange
PRC$261.18M68%−12.1%
Outside Chinese Mainland$124.83M32%+93.9%
Outside Mainland China———
Total$386.01M

From the 20-F filed Jun 5, 2026SVA

Pharmaceutical preparations

Sinovac Biotech Ltd is the 62nd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Sinovac Biotech Ltd · CIK 1084201 · Engraved from SEC EDGAR